Teva Pharmaceuticals - HealthQuill

The US drug regulator has issued its most prominent warning on the use of certain drugs to treat multiple sclerosis, saying it may cause hospitalisation and death due to a “rare but serious” allergic reaction.

US drug regulator issues warning on certain multiple sclerosis drugs

The US drug regulator has issued its most prominent warning on the use of certain drugs to treat multiple sclerosis, saying it may.

by HealthQuill
January 22, 2025
0 Comments

The European Union has announced a 1.23 billion euro initiative to prevent mental health issues and find affordable treatments for its 84 million patients in the bloc.

Drugs Health Pharma

Teva unveils insights on switching schizophrenia patients to Uzedy

September 24, 2024: Teva Pharmaceuticals presented new research demonstrating effective strategies for switching adult patients with schizophrenia from Perseris to Uzedy (risperidone extended-release.

by HealthQuill
September 24, 2024
0 Comments

Israel’s Teva Pharmaceuticals will start selling a generic version of Novo Nordisk’s type 2 diabetic drug Victoza in the US market.

Drugs Health Pharma

Teva to sell generic version of Novo Nordisk’s diabetic drug in US

Israel’s Teva Pharmaceuticals will start selling a generic version of Novo Nordisk’s type 2 diabetic drug Victoza in the US market.

by HealthQuill
June 25, 2024
0 Comments

Israel’s Teva Pharmaceuticals has sued US-based Corcept Therapeutics and Optime Care Inc., a specialty pharma, for monopolising the market for a drug used to treat a rare hormonal disorder.

Drugs Medical Pharma

Israel’s Teva Pharmaceuticals sue Corcept, Optime over drug monoploy

Israel’s Teva Pharmaceuticals has sued US-based Corcept Therapeutics and Optime Care Inc., a specialty pharma, for monopolising the market for a drug used to.